Skip to main content
Global Hemp Group Inc. logo

Global Hemp Group Inc. — Investor Relations & Filings

Ticker · GHG ISIN · CA37953Y1043 LEI · 5299002P2ETND2KOY311 CSE Manufacturing
Open in API
Filings indexed 350 across all filing types
Latest filing 2023-03-08 Regulatory Filings
Country CA Canada
Listing CSE GHG

About Global Hemp Group Inc.

https://globalhempgroup.com/

Global Hemp Group Inc. focuses on two key segments: Industrial Hemp and Biopharma. The Industrial Hemp division develops innovative, green, and sustainable solutions utilizing the whole hemp plant for environmental applications, including carbon-negative construction materials, sustainable bio-energy sources, bio-composites, textiles, and nonwovens. This strategy is executed through the Hemp Agro-Industrial Zone (HAIZ) concept, which integrates raw material supply with industrial processing. The company also maintains an R&D division dedicated to developing patented IP for hemp-based eco-friendly building materials. The Biopharma division centers on acquiring exclusive licensing of advanced Intellectual Property, notably holding exclusive perpetual licenses to Apollon Formularies' proprietary technology and patents for developing cancer treatments from natural biologics (such as medical cannabis and functional mushrooms) using an AI-based drug discovery platform.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings
2023-03-08 English
Offering document - English.pdf
Regulatory Filings
2023-03-08 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a FORM 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate, signed by the CFO certifying the review and fair presentation of the interim financial report and interim MD&A for the period ended December 31, 2022. It is a certification letter rather than the interim report itself. The document explicitly states it is a certificate and does not contain actual financial data or substantive financial analysis. According to the Certification Rule, such officer certifications should be classified as Regulatory Filings (RNS), not as the interim report (IR). The document length is short (3002 characters), consistent with a certification letter rather than a full report.
2023-03-01 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a FORM 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate signed by the CEO. It certifies the review and fair presentation of the interim financial report and interim MD&A for the period ended December 31, 2022. The document is primarily an officer certification letter and does not contain actual financial data or the interim report itself. According to the CERTIFICATION RULE, such certification documents should be classified as Regulatory Filings (RNS) rather than as the interim report (IR). The document length is short (3003 characters), and it is clearly a certification rather than a full interim report. Therefore, the correct classification is Regulatory Filings (RNS).
2023-03-01 English
Interim MD&A - English.pdf
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Management Discussion and Analysis Three Months ended December 31, 2022' and contains detailed management commentary on the company's financial results, business updates, forward-looking statements, and operational details for the quarter ended December 31, 2022. It references the company's audited annual financial statements for the year ended September 30, 2022, but the document itself is focused on the quarterly period ending December 31, 2022. The length of the document (15,000 characters) and the presence of substantive financial and operational discussion confirm it is a full report rather than a brief announcement or certification. The content matches the definition of an Interim / Quarterly Report (IR), which includes comprehensive financial report for a period shorter than a full fiscal year with actual financial data and analysis. Therefore, the appropriate classification is IR with high confidence. Q1 2023
2023-03-01 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Condensed Consolidated Interim Financial Statements Three Months Ended December 31, 2022' and contains detailed financial statements including statements of financial position, comprehensive loss, changes in equity, and cash flows for a three-month period ending December 31, 2022. It references compliance with IAS 34 'Interim Financial Reporting' and explicitly states it is an interim financial report. The document is approximately 15,000 characters long and contains substantive financial data and notes. Therefore, it is a comprehensive interim/quarterly financial report rather than a brief announcement or certification. Hence, the appropriate classification is 'Interim / Quarterly Report' (IR). Q1 2023
2023-03-01 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.